title: Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency.
authors.affiliation: National Reporting and Learning Service, National Patient Safety Agency, London W1T 5HD, UK. david.gerrett@npsa.nhs.uk
authors.forename: David
authors.initials: D
authors.lastname: Gerrett
authors.forename: Tara
authors.initials: T
authors.lastname: Lamont
authors.forename: Carol
authors.initials: C
authors.lastname: Paton
authors.forename: Thomas R E
authors.initials: TR
authors.lastname: Barnes
authors.forename: Amar
authors.initials: A
authors.lastname: Shah
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000097:blood; D018692:Antimanic Agents / Q000009:adverse effects* / Q000097:blood; D001714:Bipolar Disorder / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy*; D016903:Drug Monitoring; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects* / Q000097:blood; D010818:Practice Patterns, Physicians'
chemical_list: D000928:Antidepressive Agents; D018692:Antimanic Agents; D018020:Lithium Compounds